Designed for Nurses - CPD Accredited Course Bundles

This course is designed to equip nursing professionals with the knowledge and skills necessary to navigate Australia's evolving medical cannabis landscape. DEVELOPER'S NOTE: As nurses, we understand the growing importance of holistic care and the role medical cannabis can have in managing a multitude of conditions. Join us in this meticulously crafted course to explore the history and botany of cannabis, understand the role of the endocannabinoid system and homeostasis. Learn how to navigate TGA processes, monitor and manage potential adverse side effects and other important aspects of cannabis treatment and patient care. This course is created and endorsed by nurses who believe in the potential of medical cannabis as a vital component of integrative, modern healthcare. Preview this course by watching the video above. Estimated Duration: 5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe cannabis medicines accurately and demonstrate an understanding of the individual chemical components of the plant. Demonstrate an understanding of endocannabinoid system function. Assess the suitability of cannabis treatments in various chronic disease states. Identify appropriate patient cohorts for medical cannabis treatment. Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management. Monitor and provide titration advice around cannabinoid medicines.  Apply critical safety considerations in patient centred care. Navigate the regulatory frameworks surrounding medical cannabis provision in Australia.  Claim 5 CPD hours for eligible participants.

Designed for nurses, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go under-recognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks. With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of: Endometriosis Dysmenorrhoea Polycystic Ovary Syndrome (PCOS) Premenstrual Dysphoric Disorder (PMDD) Postpartum Depression (PPD) Breast, ovarian, and uterine cancers Perimenopause and menopause Additionally, it covers critical pregnancy-related contraindications for medical cannabis. Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes. This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients. Preview this course by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Assess medical cannabis’ therapeutic potential for treating symptoms of dysmenorrhoea, endometriosis, PCOS, PMDD, PPD, menopause, and breast, ovarian and uterine cancers considering its pharmacological interaction with the condition’s pathophysiology and efficacy, and drawbacks of current recommended treatments Identify characteristics of suitable medical cannabis strains, compounds, product types and administration methods for treating symptoms of the particular condition affecting IAFABP Identify and explain pregnancy-related contraindications for using medical cannabis

This course is an intermediate-level exploration of how to tailor medical cannabis treatment for patients by considering their prior exposure to cannabis (medical or otherwise). With a focus on identifying patients' exposure levels, nurses and nurse practitioners will learn to account for patients’ prior cannabis exposure when offering care during medical cannabis treatment. Over the course of 7 modules, discover cannabis’ interactions with the body, as well as the key identifiers, considerations and recommendations for offering safe and effective treatment. Examine the biological composition of cannabis and its pharmacological interactions with the body, gaining insight into how prior exposure affects tolerance and experience. This course forms part of a comprehensive learning path covering factors to consider when offering medical cannabis care and treatment. Preview this course by watching the video above. Estimated Duration: 6 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Identify cannabis’ biological constituents and explain their effects on the body Explain how the endocannabinoid system (ECS) maintains homeostasis and describe cannabis’ interactions with the ECS, including how exposure affects endocannabinoid tone Identify the 2 dimensions of prior cannabis exposure, and explain how to identify them in patients Explain how prior exposure may impact treatment goals and discuss considerations and recommendations for setting personalised treatment goals based on prior exposure Identify and describe common medical cannabis products and explain the considerations and recommendations for product selection based on prior cannabis exposure Discuss general recommendations for dosage and titration based on patient’s prior cannabis exposure